2) Lung resistance protein
肺耐药蛋白
1.
Expression of lung resistance protein and Multidrug resistance-associated protein in Esophageal carcinoma;
食管癌中肺耐药蛋白和多药耐药相关蛋白的表达
2.
Expression and significance of lung resistance protein in epithelial ovarian cancer;
上皮性卵巢癌组织中肺耐药蛋白的表达及意义
3.
Expression and value of lung resistance protein in bone marrow mononuclear cells of acute leukemia patients;
肺耐药蛋白在急性白血病中的表达及意义
3) lung resistance-related protein
肺耐药蛋白
1.
Objective:To investigate the expression of P-glycoprotein(P-gp),multidrug resistance-related protein(MRP),lung resistance-related protein(LRP),P53 and c-erbB-2 in untreated non-small cell lung cancer(NSCLC) and their relationship with each other.
目的:探讨P糖蛋白(P-gp)、多药耐药相关蛋白(MRP)、肺耐药蛋白(LRP)、P53蛋白及c-erbB-2蛋白在术前未经治疗的非小细胞肺癌(NSCLC)中的表达及相互间的关系。
4) LRP
肺耐药蛋白
1.
Study on expression and relations of FLK-1, LRP and caspase-3 in lung cancer;
血管内皮生长因子受体、肺耐药蛋白和半胱氨酸天冬氨酸特异性蛋白酶在肺癌中的表达及相关性研究
2.
Relationship between expression of LRP and clinical pathological features in esophageal squamous cell carcinoma;
肺耐药蛋白表达与食管鳞癌临床病理特征的关系
3.
Objective:To investigate the expression of P-glycoprotein (P-gp) and lung resistance protein (LRP) in acute leukemia and to observe the relationship between these expression levels and the clinical remission rate.
目的:研究急性白血病细胞P-糖蛋白(P-gp)、肺耐药蛋白(LRP)的表达情况,观察其表达率与临床症状及化疗缓解率的关系。
5) Lung resistance protein(LRP)
肺耐药蛋白
1.
Objective To study the clinical significance of P-glycoprotein(P-gp), glutathione-s-trannsferase(GST-π ),DNA topoisomerase(Topo Ⅱ ) and lung resistance protein(LRP) expression in gastric carcinama tissue.
目的 探讨P-糖蛋白(P-gp)、谷胱甘肽转移酶(GST-π)、拓扑异构酶Ⅱ(TopoⅡ)和肺耐药蛋白(LRP)在胃癌中的表达及临床意义。
6) MDR-TB
耐药肺结核
1.
Pharmacodynamics of Sparfloxacin Dispersible Tablet in Patients with MDR-TB;
结论:耐药肺结核病人服用司帕沙星,应注意24h体内血药浓度维持在最低杀菌浓度之上,介入治疗用药浓度应在48mg/L以上。
2.
Pharmacodynamics of Levofloxacin-methane sulfuric acid in patients with MDR-TB;
结论耐药肺结核病人服用左氧氟沙星,应注意24小时体内血药浓度维持在最低杀菌浓度MBC之上,介入治疗用药浓度应在48mg/L以上。
补充资料：耐药
耐药
见抗菌药物敏感试验。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条